Syndax Pharmaceuticals (SNDX) Capital Expenditures (2015 - 2025)
Syndax Pharmaceuticals (SNDX) recorded quarterly Capital Expenditures of $56000.0 in Q4 2025, up 300.0% quarter-over-quarter from $14000.0 in Q4 2018.
Syndax Pharmaceuticals (SNDX) Capital Expenditures (2015 - 2025) Analysis & Trends
Syndax Pharmaceuticals' Capital Expenditures history runs 5 years deep, the most recent figure standing at $56000.0 for Q4 2025.
- In Q4 2025, Capital Expenditures changed N/A year-over-year to $56000.0; the TTM figure through Dec 2025 stood at $70000.0 (up 400.0% YoY), while the FY2025 annual figure was $187000.0, changed N/A from the prior year.
- Capital Expenditures was $56000.0 for Q4 2025 at Syndax Pharmaceuticals, up from $14000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $56000.0 in Q4 2025 to a low of $56000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Syndax Pharmaceuticals | 1.69 Bn | 1.34 Bn | 53.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 56,000.00 |
| Dec 31, 2025 | 56,000.00 |
| Dec 31, 2018 | 14,000.00 |
| Dec 31, 2018 | 14,000.00 |
| Mar 31, 2018 | 173,000.00 |
| Mar 31, 2018 | 173,000.00 |
| Dec 31, 2017 | 42,000.00 |
| Dec 31, 2017 | 42,000.00 |
| Sep 30, 2017 | 1,000.00 |
| Sep 30, 2017 | 1,000.00 |
| Sep 30, 2016 | 210,000.00 |
| Sep 30, 2016 | 210,000.00 |
| Jun 30, 2016 | -22,000.00 |
| Jun 30, 2016 | -22,000.00 |
| Mar 31, 2016 | 73,000.00 |
| Mar 31, 2016 | 73,000.00 |
| Dec 31, 2015 | 31,000.00 |
| Dec 31, 2015 | 31,000.00 |
| Sep 30, 2015 | 13,000.00 |
| Sep 30, 2015 | 13,000.00 |